Order Article Reprints

Ma Y, Nenkov M, Berndt A, Abubrig M, Schmidt M, Sandhaus T, Huber O, Clement JH, Lang SM, Chen Y, et al. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers. 2024; 16(6):1170. https://doi.org/10.3390/cancers16061170

Ma, Yunxia, Miljana Nenkov, Alexander Berndt, Mohamed Abubrig, Martin Schmidt, Tim Sandhaus, Otmar Huber, Joachim H. Clement, Susanne M. Lang, Yuan Chen, and et al. 2024. "The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer" Cancers 16, no. 6: 1170. https://doi.org/10.3390/cancers16061170

Ma, Y., Nenkov, M., Berndt, A., Abubrig, M., Schmidt, M., Sandhaus, T., Huber, O., Clement, J. H., Lang, S. M., Chen, Y., & Gaßler, N. (2024). The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers, 16(6), 1170. https://doi.org/10.3390/cancers16061170